Celldex Therapeutics, Inc.Celldex Therapeutics, Inc.Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪2.55 B‬USD
−2.91USD
‪−141.43 M‬USD
‪6.88 M‬USD
‪62.84 M‬
Beta (1Y)
1.77

About Celldex Therapeutics, Inc.

CEO
Anthony S. Marucci
Headquarters
Hampton
Employees (FY)
160
Founded
1983
ISIN
US15117B2025
FIGI
BBG000FW8LZ9
Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CLDX is 38.45 USD — it has decreased by 2.98% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Celldex Therapeutics, Inc. stocks are traded under the ticker CLDX.
Celldex Therapeutics, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
CLDX stock is 4.05% volatile and has beta coefficient of 1.77. Check out the list of the most volatile stocks — is Celldex Therapeutics, Inc. there?
One year price forecast for Celldex Therapeutics, Inc. has a max estimate of 90.00 USD and a min estimate of 35.00 USD.
CLDX earnings for the last quarter are −0.81 USD whereas the estimation was −0.68 USD which accounts for −19.12% surprise. Estimated earnings for the next quarter are −0.73 USD. See more details about Celldex Therapeutics, Inc. earnings.
Celldex Therapeutics, Inc. revenue for the last quarter amounts to ‪1.52 M‬ USD despite the estimated figure of ‪583.33 K‬ USD. In the next quarter revenue is expected to reach ‪1.44 M‬ USD.
Yes, you can track Celldex Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
CLDX stock has fallen by 2.98% compared to the previous week, the month change is a 5.99% fall, over the last year Celldex Therapeutics, Inc. has showed a 12.56% increase.
CLDX net income for the last quarter is ‪−43.31 M‬ USD, while the quarter before that showed ‪−38.26 M‬ USD of net income which accounts for −13.19% change. Track more Celldex Therapeutics, Inc. financial stats to get the full picture.
Today Celldex Therapeutics, Inc. has the market capitalization of ‪2.55 B‬, it has decreased by 3.45% over the last week.
No, CLDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CLDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Celldex Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CLDX reached its all-time high on Mar 7, 2000 with the price of 3375.00 USD, and its all-time low was 1.50 USD and was reached on Mar 19, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 160.00 employees. See our rating of the largest employees — is Celldex Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Celldex Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Celldex Therapeutics, Inc. stock shows the buy signal. See more of Celldex Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Celldex Therapeutics, Inc. future price: according to them, CLDX price has a max estimate of 90.00 USD and a min estimate of 35.00 USD. Read a more detailed Celldex Therapeutics, Inc. forecast: see what analysts think of Celldex Therapeutics, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Celldex Therapeutics, Inc. EBITDA is ‪−139.03 M‬ USD, and current EBITDA margin is ‪−2.02 K‬%. See more stats in Celldex Therapeutics, Inc. financial statements.